Celltrion Calls For Harmonized Approach To ‘Biobetters’

As Latest Data Shows Benefits Of Subcutaneous Infliximab Biosimilar Remsima SC

 
• By Dave Wallace
  
Good Better Road Sign Divergent Arrows
Celltrion has highlighted divergent approaches to biobetters • Source: ferhat ozyurt / Alamy Stock Photo

More from Biosimilars

More from Products